323 related articles for article (PubMed ID: 27293888)
1. Urinary Markers of Tubular Injury in Early Diabetic Nephropathy.
Fiseha T; Tamir Z
Int J Nephrol; 2016; 2016():4647685. PubMed ID: 27293888
[TBL] [Abstract][Full Text] [Related]
2. Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients.
Fiseha T
Biomark Res; 2015; 3():16. PubMed ID: 26146561
[TBL] [Abstract][Full Text] [Related]
3. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus.
Salem MA; el-Habashy SA; Saeid OM; el-Tawil MM; Tawfik PH
Pediatr Diabetes; 2002 Mar; 3(1):37-41. PubMed ID: 15016173
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 as Biomarkers for Diabetic Kidney Disease.
Abbasi F; Moosaie F; Khaloo P; Dehghani Firouzabadi F; Fatemi Abhari SM; Atainia B; Ardeshir M; Nakhjavani M; Esteghamati A
Kidney Blood Press Res; 2020; 45(2):222-232. PubMed ID: 32008005
[TBL] [Abstract][Full Text] [Related]
6. Application of urinary N-acetyl-β-D-glucosaminidase combined with serum retinol-binding protein in early detection of diabetic nephropathy.
Lin ZH; Dai SF; Zhao JN; Jiang Y
World J Diabetes; 2023 Jun; 14(6):883-891. PubMed ID: 37383593
[TBL] [Abstract][Full Text] [Related]
7. [Clinical implication of urinary protein markers in diabetic nephropathy and interventional effects of Chinese herbal medicine].
Shi XM; Meng XJ; Wan YG; Shen SM; Luo XY; Gu LB; Yao J
Zhongguo Zhong Yao Za Zhi; 2014 Jul; 39(14):2589-94. PubMed ID: 25272479
[TBL] [Abstract][Full Text] [Related]
8. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of Early Markers of Diabetic Nephropathy by Linagliptin in Fructose-Streptozotocin-Induced Type 2 Diabetic Rats.
Oraby MA; El-Yamany MF; Safar MM; Assaf N; Ghoneim HA
Nephron; 2019; 141(4):273-286. PubMed ID: 30699409
[TBL] [Abstract][Full Text] [Related]
10. Urinary RBP as an Independent Predictor of Renal Outcome in Diabetic Nephropathy.
Cai F; Zhang L; Zhao P; Qiu F; Mukhtar AM; Ma Y; Chen J; Han F
Dis Markers; 2022; 2022():9687868. PubMed ID: 36299825
[TBL] [Abstract][Full Text] [Related]
11. Value of the intrarenal arterial resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients.
Abd El Dayem S; El Bohy Ael M; El Shehaby A
J Pediatr Endocrinol Metab; 2016 Mar; 29(3):273-9. PubMed ID: 26677884
[TBL] [Abstract][Full Text] [Related]
12. Follow Up of Value of the Intrarenal Resistivity Indices and Different Renal Biomarkers for Early Identification of Diabetic Nephropathy in Type 1 Diabetic Patients.
Dayem SAE; Bohy AEME; Hamed M; Ahmed S
Open Access Maced J Med Sci; 2017 Apr; 5(2):188-192. PubMed ID: 28507626
[TBL] [Abstract][Full Text] [Related]
13. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil Gelatinase-associated Lipocalin: As a Predictor of Early Diabetic Nephropathy in Type 2 Diabetes Mellitus.
Kaul A; Behera MR; Rai MK; Mishra P; Bhaduaria DS; Yadav S; Agarwal V; Karoli R; Prasad N; Gupta A; Sharma RK
Indian J Nephrol; 2018; 28(1):53-60. PubMed ID: 29515302
[TBL] [Abstract][Full Text] [Related]
15. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
16. Tubular damage in microalbuminuric patients with primary glomerulonephritis and diabetic nephropathy.
Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
Ren Fail; 1995 Jan; 17(1):43-9. PubMed ID: 7770643
[TBL] [Abstract][Full Text] [Related]
17. Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.
Maas RJ; van den Brand JA; Waanders F; Meijer E; Goor van H; Peters HP; Hofstra JM; Wetzels JF
Ann Clin Biochem; 2016 Jan; 53(Pt 1):51-7. PubMed ID: 25762211
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.
González J; Jatem E; Roig J; Valtierra N; Ostos E; Abó A; Santacana M; García A; Segarra A
Nephrol Dial Transplant; 2022 Oct; 37(11):2102-2110. PubMed ID: 35583251
[TBL] [Abstract][Full Text] [Related]
19. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
[TBL] [Abstract][Full Text] [Related]
20. Urinary
Siddiqui K; Al-Malki B; George TP; Nawaz SS; Rubeaan KA
3 Biotech; 2019 Mar; 9(3):66. PubMed ID: 30729090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
